Quantori, a Cambridge, MA-based provider of IT services for healthcare industries, raised $15M in Seed funding.
The round was led by Flint Capital.
The company intends to use the funds to expand globally and finalize the development of a new platform that empower technologies like diagnostics and precision medicine as well as novel biologic and small molecule drugs.
Founded in 2020 by Richard Golob, Yuriy Gankin and Vitaliy Aronov, Quantori is a provider of IT services and AI/ML products. The company offers software engineering, scientific informatics, data science, machine learning, cloud computing and AI solutions that enable biopharma companies to accelerate every stage of the pharma value chain and help healthcare organizations structure complex data sets to enhance the delivery of personalized healthcare and improve patient outcomes. Quantori employs over 700 IT professionals, bio and cheminformatics specialists and data scientists, offering a network and support spanning the United States, Canada, the UK, the Netherlands, Georgia, Armenia, Kazakhstan and Finland. The staff includes over 50 life science and healthcare Ph.D. or MD domain experts as well as industry veterans who formerly held executive positions in major global pharma companies.
Clients include Pfizer, AstraZeneca, Takeda and Biogen.
FinSMEs
12/10/2022